The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

Now, a new study suggests that vivid hallucinations—both during sleep and while awake—could point to an underlying autoimmune disorder. Published in the journal eClinicalMedicine, a recent study found ...

AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe active lupus, a retrospective study shows.

A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...

Cabaletta has been evaluating the CAR-T, called resecabtagene autoleucel or rese-cel , across six so-called RESET studies ...

Kris Aquino revealed her “pain and struggle” amid suffering from lupus flare fever for over two weeks now, appealing to the ...

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...